Novir
Novir is providing testing based on tests from various manufacturers. Such tests have either received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) or were released for use under FDA guidance, "Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency - Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers and Food and Drug Administration Staff" that was updated on May 4, 2020. Tests being performed under an EUA have not been FDA cleared or approved and Novir has completed independent validation of these tests.
Last updated on
About Novir
Founded
2020Estimated Revenue
$1M-$10MEmployees
11-50Category
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
MilwaukeeState
WisconsinCountry
United StatesNovir
Find your buyer within Novir